HR 6868119th CongressIn Committee
ACCESS Through OTC Innovation Act
Standard Summary
Balanced plain-English summary
This bill would amend the Federal Food, Drug, and Cosmetic Act to require the Secretary of Health and Human Services to use the least burdensome appropriate means when evaluating requests for administrative orders involving over-the-counter monograph drugs. It also requires meetings with requestors when published reports are insufficient and mandates meeting minutes and administrative records.
Key Points
- 1Directs HHS to apply the least burdensome appropriate approach for OTC monograph drug administrative order requests.
- 2Requires the Secretary to meet with requestors if published reports are insufficient to support requested findings.
- 3Requires meeting minutes and written recommendations to be included in the administrative record.
- 4Preserves existing criteria for complete requests and for determining whether a drug is generally recognized as safe and effective.
Impact Areas
Over-the-counter drug manufacturersConsumersFood and Drug AdministrationDepartment of Health and Human ServicesHealthcare product innovators
Generated by deepseek/deepseek-v4.1-flash-1017Nov 18, 2026